Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)
- Treatment of chronic hemodialysis patients with low-dose fenofibrate
- Expect strong growth from US in FY13-14 - Moneycontrol.com
- Expect strong growth from US in FY13-14Moneycontrol
- Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... - Seeking Alpha
- Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care
- Santarus Reports First Quarter 2012 Financial Results - MarketWatch (press release)
- Santarus Reports First Quarter 2012 Financial ResultsMarketWatch (press release)FENOGLIDE(fenofibrate) tablets new prescriptions grew 17% and total prescriptions increased 11% for the four-week period ending April 20, 2012, compared with the four-week period ending February 3, 2012, which was just prior to Santarus' initiation of
- Santarus Announces Presentation of UCERIS Phase III Extended Use Data at ... - MarketWatch (press release)
- Santarus Announces Presentation of UCERIS Phase III Extended Use Data at
